Aprea Therapeutics, Inc.Aprea Therapeutics, Inc.Aprea Therapeutics, Inc.

Aprea Therapeutics, Inc.

No trades
See on Supercharts

APRE fundamentals

An in-depth look to Aprea Therapeutics, Inc. operating, investing, and financing activities

APRE free cash flow for Q3 24 is -2.63 M USD. For 2023, APRE free cash flow was -12.27 M USD and operating cash flow was -12.18 M USD.

Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Free cash flowYoY growth